Comparison of apolipoprotein D determination methods in breast cancer

Anticancer Research

Volumn 28, Issue 2 B, 2008, Pages 1151-1160

  Søiland, Håvard ^a,c   Skaland, Ivar ^a   Janssen, Emiel A M ^a   Gudlaugsson, Einar ^a   Körner, Hartwig ^a,c   Varhaug, Jan Erik ^b,c   Søreide, Jon Arne ^a,c   Baak, Jan P A ^a,c,d  

^a STAVANGER UNIVERSITY HOSPITAL   (Norway)

^b HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^c UNIVERSITY OF BERGEN   (Norway)

^d VU UNIVERSITY AMSTERDAM   (Netherlands)

Author keywords

Apolipoprotein D; Breast cancer; Immunoelectrophoresis in cytosol; Immunohistochemistry; Tissue microarray; Whole sections

Indexed keywords

APOLIPOPROTEIN D;

ADULT; AGED; ARTICLE; BREAST CANCER; BREAST CARCINOMA; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; CYST; CYTOSOL; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOELECTROPHORESIS; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MEDICAL TECHNOLOGY; PRIORITY JOURNAL; PROTEIN DETERMINATION; SENSITIVITY ANALYSIS; TISSUE MICROARRAY;

AGED; APOLIPOPROTEINS D; BREAST NEOPLASMS; CYTOSOL; FEMALE; GLYCOPROTEINS; HUMANS; IMMUNOELECTROPHORESIS; IMMUNOHISTOCHEMISTRY; MEMBRANE TRANSPORT PROTEINS; MICROARRAY ANALYSIS; MIDDLE AGED; STAINING AND LABELING; TUMOR MARKERS, BIOLOGICAL;

EID: 42549139630     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Nicolini A, Carpi A and Tarro G: Biomolecular markers of breast cancer. Front Biosci 11: 1818-1843, 2006.
2. Sebastiani V, Botti C, Di Tondo U, Visca P, Pizzuti L, Santeusanio G and Alo PL: Tissue microarray analysis of FAS, Bcl-2, Bcl-x, ER, PgR, Hsp60, p53 and Her2-neu in breast carcinoma. Anticancer Res 26: 2983-2987, 2006.
3. Koumoundourou D, Kassimatis T, Zolota V, Tzorakoeleftherakis E, Ravazoula P, Vassiliou V, Karmandis D and Varakis J: Prognostic significance of TGFbeta-1 and pSmad2/3 in breast cancer patients with T1-2, N0 tumours. Anticancer Res 27: 2613-2620, 2007.
4. Della Rovere F, Granata A, Familiari D, D'Arrigo G, Mondello B and Basile G: Mast cells in invasive ductal breast cancer: different behavior in high and minimum hormone-receptive cancers. Anticancer Res 27: 2465-2471, 2007.
5. Rassart E, Bedirian A, Do Carmo S, Guinard O, Sirois J, Terrisse L and Milne R: Apolipoprotein D. Biochim Biophys Acta 1482: 185-198, 2000.
6. Bratt T: Lipocalins and cancer. Biochim Biophys Acta 1482: 318-326, 2000.
7. Søiland H, Søreide K, Janssen EA, Kørner H, Baak JP and Søreide JA: Emerging concepts of apolipoprotein D with possible implications for breast cancer. Cell Oncol 29: 195-209, 2007.
8. Simard J, Dauvois S, Haagensen DE, Levesque C, Merand Y and Labrie F: Regulation of progesterone-binding breast cyst protein GCDFP-24 secretion by estrogens and androgens in human breast cancer cells: a new marker of steroid action in breast cancer. Endocrinology 126: 3223-3231, 1990.
9. Morais Cabral JH, Atkins GL, Sanchez LM, Lopez-Boado YS, Lopez-Otin C and Sawyer L: Arachidonic acid binds to apolipoprotein D: implications for the protein's function. FEBS Lett 366: 53-56, 1995.
10. Lea OA: Binding properties of progesterone-binding Cyst protein, PBCP. Steroids 52: 337-338, 1988.
11. Lea OA, Kvinnsland S and Thorsen T: Progesterone-binding cyst protein in human breast tumor cytosol. Cancer Res 47: 6189-6192, 1987.
12. Diez-Itza I, Vizoso F, Merino AM, Sanchez LM, Tolivia J, Fernandez J, Ruibal A and Lopez-Otin C: Expression and prognostic significance of apolipoprotein D in breast cancer. Am J Pathol 144: 310-320, 1994.
13. Søiland H, Skaland I, van Diermen B, Janssen EAM, Körner H, Varhaug JE, Søreide JA and Baak JP: Androgen receptor determination in breast cancer: a comparison of the dextrancoated charcoal method and quantitative imunohistochemical analysis. Appl Immunohistochem Mol Morphol, in press, 2007.
14. Søreide JA, Lea OA, Anda O, Skarstein A, Varhaug JE and Kvinnsland S: Progesterone-binding cyst protein (PBCP) in operable breast cancer: correlations with prognostic factors and predictive value for effect of adjuvant tamoxifen treatment. Anticancer Res 11: 601-605, 1991.
15. Tavassoli FA and Devilee P: World Health Organization Classification of Tumours; Pathology and Genetics; Tumours of the Breast and Female Genital Organs; IARC-press, Lyon, France, pp. 8-48, 2003.
16. Sobin LH and Witterkind C: TNM Classifications of Malignant Tumors, 6th. edition. International Union Classification of Cancer (UICC): John Wiley & Sons, Hoboken, New Jersey, pp. 131-141, 2002.
17. Søreide JA, Lea OA and Kvinnsland S: Progesterone binding cyst protein (PBCP) in primary breast cancer: a new prognostic factor? Breast Cancer Res Treat 9: 123-128, 1987.
18. Janssen EA, Søiland H, Skaland I, Gudlaugson E, Kjellevold KH, Nysted A, Søreide JA and Baak JP: Comparing the prognostic value of PTEN and Akt expression with the mitotic activity index in adjuvant chemotherapy-treated node-negative breast cancer patients aged <55 years. Cell Oncol 29: 25-35, 2007.
19. Do Carmo S, Levros LC Jr. and Rassart E: Modulation of apolipoprotein D expression and translocation under specific stress conditions. Biochim Biophys Acta 1773: 954-969, 2007.
20. Hodi Z, Chakrabarti J, Lee AH, Ronan JE, Elston CW, Cheung KL, Roberston JF and Ellis IO: The reliability of assessment of oestrogen receptor expression on needle core biopsy specimens of invasive carcinomas of the breast. J Clin Pathol 60: 299-302, 2007.
21. Lea OA, Thorsen T and Kvinnsland S: Extracellular proteins in breast tumor cytosol. Anticancer Res 7: 113-117, 1987.
22. Zlobec I, Steele R, Terracciano L, Jass JR and Lugli A: Selecting immunohistochemical cut-off scores for novel biomarkers of progression and survival in colorectal cancer. J Clin Pathol 60: 1112-1116, 2007.
23. Zweig MH and Campbell G: Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine. Clin Chem 39: 561-577, 1993.
24. Baker SG: The central role of receiver operating characteristic (ROC) curves in evaluating tests for the early detection of cancer. J Natl Cancer Inst 95: 511-515, 2003.
25. Online homepage: Norwegian Breast Cancer Group, http://www.nbcg.no/ blaaboka/adjuvant.115.pdf, p13, Sited: December 4, 2007.
26. Do Carmo S, Seguin D, Milne R and Rassart E: Modulation of apolipoprotein D and apolipoprotein E mRNA expression by growth arrest and identification of key elements in the promoter. J Biol Chem 277: 5514-5523, 2002.
27. Thomas EA, George RCA and Sutcliffe JG: Apolipoprotein D modulates arachidonic acid signaling in cultured cells: implications for psychiatric disorders. Prostaglandins Leukot Essent Fatty Acids 69: 421-427, 2003.
28. Sarjeant JM, Lavrie A, Kinnear C, Yablonsky S, Leung W, Massaeli H, Prichett W, Veinot JB, Rassart E and Rabinowich M: Apolipoprotein D inhibits platelet-derived growth factor-BB-induced vascular smooth muscle cell proliferation by preventing translocation of phosphorylated extracellular signal related kinase 1/2 to the nucleus. Arterioscler Thromb Vasc Biol 23: 2172-2177, 2003.
29. Thomas EA, Copolov DL and Sutcliffe JG: From pharmacotherapy to pathophysiology: emerging mechanisms of apolipoprotein D in psychiatric disorders. Curr Mol Med 3: 408-418, 2003.
30. Provost PR, Marcel YL, Milne RW, Weech PK and Rassart E: Apolipoprotein D transcription occurs specifically in nonproliferating quiescent and senescent fibroblast cultures. FEBS Lett 290: 139-141, 1991.
31. West RB, Nuyten DS, Subramanian S, Nielsen TO, Corless CL, Rubin BP, Montgomery K, Zhu S, Patel R, Hernandez-Boussaed T, Goldblum JR, Brown PO, van de Vijver M and van de Rijn M: Determination of stromal signatures in breast carcinoma. PLoS Biol 3: 1101-1110, 2005.
32. Online Database: The Online Mendelian Inheritance in Man (OMIM) gene map: www.ncbi.nlm.nih.gov/mapview/map_search.cgi?taxid=9606&query=APOD, In. John Hopkins University, 1996-2005. Sited October 7, 2007.
33. Janssen EA, Baak JP, Guervos MA, van Diest PJ, Jiwa M and Hermsen MA: In lymph node-negative invasive breast carcinomas, specific chromosomal aberrations are strongly associated with high mitotic activity and predict outcome more accurately than grade, tumour diameter, and oestrogen receptor. J Pathol 201: 555-561, 2003.
34. Baak JP, van Diest PJ, Voorhorst FJ, van der Wall E, Beex LV, Vermorken JB and Janssen EAM: Prospective multicenter validation of the independent prognostic value of the mitotic activity index in lymph node-negative breast cancer patients younger than 55 years. J Clin Oncol 23: 5993-6001, 2005.
35. Frenette Charron JB, Breton G, Badawi M and Sarhan F: Molecular and structural analyses of a novel temperature stress-induced lipocalin from wheat and Arabidopsis. FEBS Lett 517: 129-132, 2002.
36. Sanchez D, Lopez-Arias B, Torroja L, Canal I, Wang X, Bastiani MJ and Gandfornina MD: Loss of glial lazarillo, a homolog of apolipoprotein D, reduces lifespan and stress resistance in Drosophila. Curr Biol 16: 680-686, 2006.